NEW YORK (GenomeWeb News) – Precision Biosciences said today that the US Patent and Trademark Office has granted the firm's request to reexamine a pair of US patents that Cellectis has asserted against Precision in ongoing patent-infringement litigation.

The patents, US Nos. 6,610,545 and 7,309,605, deal with DNA vectors that can be used in gene mapping and site-directed gene insertion. Cellectis has a license to the patents, which are owned by the Institut Pasteur and Universite Pierre et Marie Curie.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.